Home
SPRC
SPRC News

Latest SciSparc Ltd. (SPRC) News on December 19, 2024

SciSparc Provides Updates on Status of Spin-off of its Advanced Clinical Stage Pharmaceutical Portfolio to a Publicly Traded Company

GlobeNewswire

2 days ago

SciSparc Provides Updates on Status of Spin-off of its Advanced Clinical Stage Pharmaceutical Portfolio to a Publicly Traded Company

Jeffs’ Brands announces trademark registration approval for Wellution

TipRanks

19 days ago

Jeffs’ Brands announces trademark registration approval for Wellution

SciSparc receives FDA approval for trial for Tourette syndrome therapy

Clinical Trials Arena

3 months ago

SciSparc receives FDA approval for trial for Tourette syndrome therapy

SciSparc Secures FDA Green Light to US Launch of its Pivotal Phase IIb Clinical Trial for Breakthrough Tourette Syndrome Treatment

GlobeNewswire

3 months ago

SciSparc Secures FDA Green Light to US Launch of its Pivotal Phase IIb Clinical Trial for Breakthrough Tourette Syndrome Treatment

SciSparc Signs Non-Binding Letter of Intent to Sell Stake in MitoCareX

GlobeNewswire

3 months ago

SciSparc Signs Non-Binding Letter of Intent to Sell Stake in MitoCareX

SciSparc Receives FDA Approval to Initiate Phase IIb Clinical Trial for Tourette Syndrome Treatment

GlobeNewswire

3 months ago

SciSparc Receives FDA Approval to Initiate Phase IIb Clinical Trial for Tourette Syndrome Treatment

MT Newswires

3 months ago

Scisparc Submits FDA Investigational New Drug Application for Tourette Syndrome Treatment

SciSparc Takes Major Step Forward with IND Application submitted to the FDA for Phase IIb Clinical Trial for Tourette Syndrome Treatment

GlobeNewswire

3 months ago

SciSparc Takes Major Step Forward with IND Application submitted to the FDA for Phase IIb Clinical Trial for Tourette Syndrome Treatment

MT Newswires

3 months ago

Clearmind Applies for Patent on Anti-Addiction Combination Therapy -- Shares Up After Hours

SciSparc-Clearmind Medicine Collaboration Announces the Publication of an International Patent Application for Pioneering Ibogaine Combination Therapy

GlobeNewswire

3 months ago

SciSparc-Clearmind Medicine Collaboration Announces the Publication of an International Patent Application for Pioneering Ibogaine Combination Therapy

SciSparc Advances $1.85 million Loan to AutoMax, Following AutoMax’s Direct Import Agreement with Major Chinese Vehicle Manufacturer

GlobeNewswire

3 months ago

SciSparc Advances $1.85 million Loan to AutoMax, Following AutoMax’s Direct Import Agreement with Major Chinese Vehicle Manufacturer

Clearmind Medicine Announces Publication of International Patent Application for Innovative MDMA-Based Combination Treatment

GlobeNewswire

3 months ago

Clearmind Medicine Announces Publication of International Patent Application for Innovative MDMA-Based Combination Treatment

SciSparc-Clearmind Medicine Collaboration Leads to Publication of International Patent Application for Innovative MDMA-Based Combination Treatment

GlobeNewswire

3 months ago

SciSparc-Clearmind Medicine Collaboration Leads to Publication of International Patent Application for Innovative MDMA-Based Combination Treatment

SciSparc-Clearmind Medicine Collaboration Leads to Publication of Application for Innovative Ketamine-Based Combination

GlobeNewswire

4 months ago

SciSparc-Clearmind Medicine Collaboration Leads to Publication of Application for Innovative Ketamine-Based Combination

SciSparc Grants Global Rights for Pain Therapy to Biotech Company in Agreement Worth up to $6 Million

GlobeNewswire

4 months ago

SciSparc Grants Global Rights for Pain Therapy to Biotech Company in Agreement Worth up to $6 Million

SciSparc secures final approval in Israel to start Tourette’s Syndrome trial

Clinical Trials Arena

4 months ago

SciSparc secures final approval in Israel to start Tourette’s Syndrome trial

SciSparc seeks FDA IND clearance for Phase IIb Tourette Syndrome treatment trial

Clinical Trials Arena

4 months ago

SciSparc seeks FDA IND clearance for Phase IIb Tourette Syndrome treatment trial

SciSparc Submitted IND Application to the FDA for SCI-110 Phase IIb Clinical Trial for Patients with Tourette Syndrome

GlobeNewswire

4 months ago

SciSparc Submitted IND Application to the FDA for SCI-110 Phase IIb Clinical Trial for Patients with Tourette Syndrome

SciSparc: MitoCareX Appointed Professor Nir Peled, Seasoned Oncologist, to its Scientific Advisory Board

GlobeNewswire

4 months ago

SciSparc: MitoCareX Appointed Professor Nir Peled, Seasoned Oncologist, to its Scientific Advisory Board

SciSparc Announces Enrollment of the First Five Patients in the Clinical Trial of its Innovative SCI-210 Treatment

GlobeNewswire

4 months ago

SciSparc Announces Enrollment of the First Five Patients in the Clinical Trial of its Innovative SCI-210 Treatment

SciSparc and Polyrizon sign global agreement for pain therapy

Pharmaceutical Technology

4 months ago

SciSparc and Polyrizon sign global agreement for pain therapy

SciSparc Finalizes Exclusive Global Out-Licensing Agreement for its Pain Therapy Valued at $3 million

GlobeNewswire

4 months ago

SciSparc Finalizes Exclusive Global Out-Licensing Agreement for its Pain Therapy Valued at $3 million

SciSparc Updates Regarding the Status of the AutoMax Merger

GlobeNewswire

4 months ago

SciSparc Updates Regarding the Status of the AutoMax Merger

SciSparc’s Collaboration with Clearmind Medicine Continues to Bear Fruit With New Scientific Article Showing MEAI Potential as a Novel Weight Loss Drug

GlobeNewswire

4 months ago

SciSparc’s Collaboration with Clearmind Medicine Continues to Bear Fruit With New Scientific Article Showing MEAI Potential as a Novel Weight Loss Drug

SciSparc: MitoCareX Confirms Potential Significant Role of its Drug Target in Non-Small Cell Lung Cancer

GlobeNewswire

5 months ago

SciSparc: MitoCareX Confirms Potential Significant Role of its Drug Target in Non-Small Cell Lung Cancer

MT Newswires

5 months ago

Scisparc Signs Non-Binding Letter of Intent for Out-Licensing of Potential Pain Treatment

SciSparc Signs Non-Binding Letter of Intent for Exclusive Global Out-Licensing of Pain Treatment for Approximately $6 million

GlobeNewswire

5 months ago

SciSparc Signs Non-Binding Letter of Intent for Exclusive Global Out-Licensing of Pain Treatment for Approximately $6 million

MT Newswires

5 months ago

SciSparc Receives Nasdaq Noncompliance Notice

SciSparc Ltd. Announces Receipt of Nasdaq Minimum Bid Price Notification

GlobeNewswire

5 months ago

SciSparc Ltd. Announces Receipt of Nasdaq Minimum Bid Price Notification

MT Newswires

5 months ago

SciSparc Seeks Patent for Obesity Drug Ingredient's Composition

SciSparc Announces U.S. Patent Application for Treating Metabolic Syndrome and Weight Loss

GlobeNewswire

5 months ago

SciSparc Announces U.S. Patent Application for Treating Metabolic Syndrome and Weight Loss

MT Newswires

5 months ago

SciSparc Signs Non-Binding Letter of Intent to Spin Off Advanced Clinical Stage Pharmaceutical Portfolio

SciSparc Signs Non-Binding Letter of Intent for Spin Off of Advanced Clinical Stage Pharmaceutical Portfolio to Publicly Traded Company

GlobeNewswire

5 months ago

SciSparc Signs Non-Binding Letter of Intent for Spin Off of Advanced Clinical Stage Pharmaceutical Portfolio to Publicly Traded Company

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

Yahoo Finance Video

6 months ago

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

GlobeNewswire

6 months ago

Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis

California seeks company profits in Big Oil climate lawsuit

Reuters

6 months ago

California seeks company profits in Big Oil climate lawsuit

USA TODAY

6 months ago

S&P 500, Nasdaq post record closing highs; Fed meeting, CPI ahead

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

GlobeNewswire

6 months ago

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Business Wire

6 months ago

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

Business Wire

6 months ago

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

GlobeNewswire

6 months ago

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

Business Wire

6 months ago

Net Asset Value(s)

Huawei Reveals How to Reach Premium Asian Tourists at Digital Tourist 2024

PR Newswire

6 months ago

Huawei Reveals How to Reach Premium Asian Tourists at Digital Tourist 2024

Dstny honored with 'Employee Wellbeing Award'

PR Newswire

6 months ago

Dstny honored with 'Employee Wellbeing Award'

MOURI Tech Announces Acquisition of Vertisystem, Enhancing IT Service Offerings and Extending Market Presence

Business Wire

6 months ago

MOURI Tech Announces Acquisition of Vertisystem, Enhancing IT Service Offerings and Extending Market Presence

RETRANSMISSION: First Hydrogen's FCEV Completes Successful Trial with Amazon

Newsfile

6 months ago

RETRANSMISSION: First Hydrogen's FCEV Completes Successful Trial with Amazon

Global Automotive HMI Market Size To Worth USD 75.3 Billion By 2033 l CAGR 12.36%

GlobeNewswire

6 months ago

Global Automotive HMI Market Size To Worth USD 75.3 Billion By 2033 l CAGR 12.36%

Entrust Enables Governments to Transform Citizen Interactions with Digital Identities

Business Wire

6 months ago

Entrust Enables Governments to Transform Citizen Interactions with Digital Identities

Amber Therapeutics Closes $100 Million Series A Financing to Advance Breakthrough Amber-UI Neuromodulation Therapy for Mixed Urinary Incontinence towards US FDA Approval

GlobeNewswire

6 months ago

Amber Therapeutics Closes $100 Million Series A Financing to Advance Breakthrough Amber-UI Neuromodulation Therapy for Mixed Urinary Incontinence towards US FDA Approval

Start Proud Opens the Market

CNW Group

6 months ago

Start Proud Opens the Market

Will recreational pot go on sale soon in Ohio? Medical marijuana stores can now apply to sell it

Associated Press Finance

6 months ago

Will recreational pot go on sale soon in Ohio? Medical marijuana stores can now apply to sell it

Business Wire

6 months ago

Form 8.3 - Darktrace plc

Dow Jones Trims Losses As Yields Spike On Jobs Data; GameStop Dives

Investor's Business Daily

6 months ago

Dow Jones Trims Losses As Yields Spike On Jobs Data; GameStop Dives

May jobs reports signals Fed's soft landing: US Labor Secretary

Yahoo Finance Video

6 months ago

May jobs reports signals Fed's soft landing: US Labor Secretary

NICE to Webcast Financial Analyst and Investor Day at Interactions 2024

Business Wire

6 months ago

NICE to Webcast Financial Analyst and Investor Day at Interactions 2024

Notification of major holding in Kindred Group plc

PR Newswire

6 months ago

Notification of major holding in Kindred Group plc

Business Wire

6 months ago

Form 8.3 - DS Smith plc

SciSparc Secures Strategic Advantage with Grant of European Patent

GlobeNewswire

7 months ago

SciSparc Secures Strategic Advantage with Grant of European Patent

SciSparc to Acquire AutoMax

GlobeNewswire

8 months ago

SciSparc to Acquire AutoMax

SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating Depression

GlobeNewswire

9 months ago

SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating Depression

SciSparc: MitoCareX Unveils Groundbreaking Discovery of Small Molecule Structure in Anti-Cancer Research

GlobeNewswire

9 months ago

SciSparc: MitoCareX Unveils Groundbreaking Discovery of Small Molecule Structure in Anti-Cancer Research

SciSparc Granted Another Patent, Strengthening its Core Technology in Canada

GlobeNewswire

9 months ago

SciSparc Granted Another Patent, Strengthening its Core Technology in Canada

SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial

GlobeNewswire

9 months ago

SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial

SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure

GlobeNewswire

9 months ago

SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure

SciSparc Announces Enrollment of First Patient for its Clinical Trial for Children with Autism Spectrum Disorder

GlobeNewswire

9 months ago

SciSparc Announces Enrollment of First Patient for its Clinical Trial for Children with Autism Spectrum Disorder

SciSparc Granted Patent for Core Technology in Multiple Jurisdictions in Europe

GlobeNewswire

9 months ago

SciSparc Granted Patent for Core Technology in Multiple Jurisdictions in Europe

SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management Technology

GlobeNewswire

9 months ago

SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management Technology

SciSparc Delivers Treatment for Autism Spectrum Disorder Clinical Trial Enabling Commencement of Dosing

GlobeNewswire

10 months ago

SciSparc Delivers Treatment for Autism Spectrum Disorder Clinical Trial Enabling Commencement of Dosing

EXCLUSIVE: Psychedelic-Focused Firm Clearmind Medicine Submits Three New International Patent Applications For MDMA, Ibogaine And Ketamine Compounds

Benzinga

10 months ago

EXCLUSIVE: Psychedelic-Focused Firm Clearmind Medicine Submits Three New International Patent Applications For MDMA, Ibogaine And Ketamine Compounds

SciSparc-Clearmind Partnership Yields Three New International Patent Applications for MDMA, Ibogaine and Ketamine Compounds

GlobeNewswire

10 months ago

SciSparc-Clearmind Partnership Yields Three New International Patent Applications for MDMA, Ibogaine and Ketamine Compounds

Clearmind Medicine Submits Three Additional International Patent Applications for Innovative MDMA, Ibogaine and Ketamine Compounds

GlobeNewswire

10 months ago

Clearmind Medicine Submits Three Additional International Patent Applications for Innovative MDMA, Ibogaine and Ketamine Compounds

SciSparc and Clearmind Continue to Strengthen International Patent Portfolio with Next Generation Classic Psychedelic-Based Compounds

GlobeNewswire

10 months ago

SciSparc and Clearmind Continue to Strengthen International Patent Portfolio with Next Generation Classic Psychedelic-Based Compounds

Clearmind Medicine Submits Three International Patent Applications for Next Generation Classic Psychedelic-Based Compounds

GlobeNewswire

10 months ago

Clearmind Medicine Submits Three International Patent Applications for Next Generation Classic Psychedelic-Based Compounds

Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

The 36% return this week takes Akso Health Group's (NASDAQ:AHG) shareholders one-year gains to 271%

Simply Wall St.

a year ago

The 36% return this week takes Akso Health Group's (NASDAQ:AHG) shareholders one-year gains to 271%

SciSparc Announces Initiation of Patient Recruitment for its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder

GlobeNewswire

a year ago

SciSparc Announces Initiation of Patient Recruitment for its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder

SELLAS Life Sciences to Present SLS009 Phase 1 Data from Acute Myeloid Leukemia Patients at the 2024 European School of Haematology (ESH) Conference

GlobeNewswire

a year ago

SELLAS Life Sciences to Present SLS009 Phase 1 Data from Acute Myeloid Leukemia Patients at the 2024 European School of Haematology (ESH) Conference

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 01/25/2024

Southern States Bancshares Inc (SSBK) Reports Mixed Q4 Earnings Amid Interest Rate Challenges

GuruFocus.com

a year ago

Southern States Bancshares Inc (SSBK) Reports Mixed Q4 Earnings Amid Interest Rate Challenges

SciSparc Ltd. Announces $20 Million Standby Equity Purchase Agreement

GlobeNewswire

a year ago

SciSparc Ltd. Announces $20 Million Standby Equity Purchase Agreement

Artelo Biosciences Announces Publication of New Peer-Reviewed Pre-Clinical Research Demonstrating ART26.12’s Effectiveness in Treating and Preventing Oxaliplatin-Induced Peripheral Neuropathy

GlobeNewswire

a year ago

Artelo Biosciences Announces Publication of New Peer-Reviewed Pre-Clinical Research Demonstrating ART26.12’s Effectiveness in Treating and Preventing Oxaliplatin-Induced Peripheral Neuropathy

Analysts Are Optimistic We'll See A Profit From Sunshine Biopharma, Inc. (NASDAQ:SBFM)

Simply Wall St.

a year ago

Analysts Are Optimistic We'll See A Profit From Sunshine Biopharma, Inc. (NASDAQ:SBFM)

Acurx Pharmaceuticals to Present at the Microcap Conference, January 31, 2024 - February 1, 2024

PR Newswire

a year ago

Acurx Pharmaceuticals to Present at the Microcap Conference, January 31, 2024 - February 1, 2024

GuruFocus.com

a year ago

Ames National Corp (ATLO) Reports Decline in Year-End Earnings Amid Rising Interest Expenses

Myomo Announces Closing of $6 Million Registered Direct Offering of Common Stock Priced At-the-Market

Business Wire

a year ago

Myomo Announces Closing of $6 Million Registered Direct Offering of Common Stock Priced At-the-Market

SciSparc Advances the Acquisition Process of a Leading Vehicle Importer Company in Israel with the provision of a Bridge Loan of $1.4 million

GlobeNewswire

a year ago

SciSparc Advances the Acquisition Process of a Leading Vehicle Importer Company in Israel with the provision of a Bridge Loan of $1.4 million

ChromaDex Corporation's (NASDAQ:CDXC) Shift From Loss To Profit

Simply Wall St.

a year ago

ChromaDex Corporation's (NASDAQ:CDXC) Shift From Loss To Profit

Vintage Wine Estates Restructures Organization, Initiates Cost Cuts and Simplifies Business Model

Business Wire

a year ago

Vintage Wine Estates Restructures Organization, Initiates Cost Cuts and Simplifies Business Model

Freight Technologies Inc. Secures Contract with Kawasaki

GlobeNewswire

a year ago

Freight Technologies Inc. Secures Contract with Kawasaki

TSR (NASDAQ:TSRI) Is Experiencing Growth In Returns On Capital

Simply Wall St.

a year ago

TSR (NASDAQ:TSRI) Is Experiencing Growth In Returns On Capital

Here’s Why Aristotle Small Cap Equity Strategy Sold Coherus BioSciences (CHRS)

Insider Monkey

a year ago

Here’s Why Aristotle Small Cap Equity Strategy Sold Coherus BioSciences (CHRS)

ESGL Holdings Limited Expands Market Presence with Incorporation of ESG Chemicals Sdn Bhd in Malaysia

GlobeNewswire

a year ago

ESGL Holdings Limited Expands Market Presence with Incorporation of ESG Chemicals Sdn Bhd in Malaysia

Lichen China Limited's (NASDAQ:LICN) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?

Simply Wall St.

a year ago

Lichen China Limited's (NASDAQ:LICN) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?

SciSparc and Clearmind Medicine Reflect on Successful Collaboration in 2023 Aiming to Upgrade Wide Range of Psychedelic-Based Treatments

GlobeNewswire

a year ago

SciSparc and Clearmind Medicine Reflect on Successful Collaboration in 2023 Aiming to Upgrade Wide Range of Psychedelic-Based Treatments

Clearmind Medicine and SciSparc Reflect on Successful Collaboration in 2023 Aiming to Upgrade Wide Range of Psychedelic- Based Treatments

GlobeNewswire

a year ago

Clearmind Medicine and SciSparc Reflect on Successful Collaboration in 2023 Aiming to Upgrade Wide Range of Psychedelic- Based Treatments

NeuroBo to Participate in Industry and Investor Conferences in January

PR Newswire

a year ago

NeuroBo to Participate in Industry and Investor Conferences in January

Comstock (LODE) Executes First Commercial Biorefinery Deal

Zacks

a year ago

Comstock (LODE) Executes First Commercial Biorefinery Deal

NeuroBo Pharmaceuticals Submits IND Application to the FDA for a Phase 1 Clinical Trial of DA-1726 for the Treatment of Obesity

PR Newswire

a year ago

NeuroBo Pharmaceuticals Submits IND Application to the FDA for a Phase 1 Clinical Trial of DA-1726 for the Treatment of Obesity

Kaival Brands Appoints Executive Chairman Barry Hopkins as Interim Chief Executive Officer and President

GlobeNewswire

a year ago

Kaival Brands Appoints Executive Chairman Barry Hopkins as Interim Chief Executive Officer and President

Co-Diagnostics, Inc. Completes Submission to FDA for Co-Dx PCR Pro

PR Newswire

a year ago

Co-Diagnostics, Inc. Completes Submission to FDA for Co-Dx PCR Pro

Share on Social Networks: